Cannabix Technol Stock Price, News & Analysis

Cannabix Technologies Inc. develops breath-based detection technologies for identifying recent marijuana and alcohol use. The company focuses on workplace safety, law enforcement applications, and laboratory testing environments where accurate and rapid substance detection is critical.

Marijuana Breathalyzer Technology

The company's Marijuana Breath Test (MBT) system represents a technological approach to detecting delta-9 tetrahydrocannabinol (THC), the psychoactive component of cannabis, through breath analysis. Unlike traditional drug testing methods that can detect cannabis use from days or weeks prior, breath-based testing aims to identify recent consumption patterns that may align more closely with potential impairment timeframes.

The technology employs field asymmetric waveform ion mobility spectrometry (FAIMS), which separates and identifies molecules based on their unique movement patterns when ionized in high electric fields. Each molecule type exhibits distinct ion mobility characteristics determined by its mass, shape, and charge. The FAIMS device functions as a molecular filter, isolating specific target compounds from background substances for detection and analysis.

The MBT system incorporates a handheld Breath Collection Unit (BCU) that captures breath samples into specialized cartridges designed for preservation and transport to laboratory facilities. These samples undergo analysis using liquid chromatography-mass spectrometry (LC-MS), a gold-standard analytical technique in forensic chemistry. The company has also developed the Mass Spectrometer Breath Sampler (MSBS), a hardware device enabling direct breath sample analysis without pre-preparation steps, potentially reducing turnaround times to minutes rather than hours or days.

Alcohol Screening Systems

BreathLogix represents the company's autonomous alcohol screening platform designed for high-volume workplace environments in safety-sensitive industries including mining, construction, and oil and gas operations. The system enables zero-tolerance alcohol screening for employees, contractors, and visitors entering work sites or facilities.

Available in wall-mounted and portable configurations, BreathLogix devices offer both straw-based and contactless testing modes. The screening process completes in approximately 20 seconds, facilitating efficient testing of large groups without creating operational bottlenecks at access points. The devices feature water and dust-resistant construction suitable for both indoor and outdoor industrial environments.

BreathLogix has received approval from the U.S. National Highway Traffic Safety Administration (NHTSA) as meeting federal model specifications for screening devices, fulfilling requirements for workplace testing in Department of Transportation (DOT)-regulated industries. The system incorporates patent-pending pre-calibrated sensor cartridge technology, allowing site administrators to maintain devices without specialized calibration equipment or technician service visits.

The BreathLogix Connect (BLC) cloud platform provides real-time data management through Amazon Web Services (AWS) infrastructure. Managers and administrators access a web-based reporting portal displaying test results, compliance metrics, and operational analytics from connected devices across multiple locations.

Intellectual Property Portfolio

The company has built a patent portfolio protecting various aspects of its breath analysis technologies. Canadian patent No. 2887841 entitled "Cannabis Drug Detection Device" covers foundational detection methods. U.S. patent 17/019728 protects innovations in FAIMS-based marijuana breathalyzer technology, encompassing work in ion mobility spectrometry, non-volatile molecule sampling, and fluid dynamics applications.

Cannabix has licensed University of Florida U.S. Patent 8,237,118 ("Partial Ovoidal FAIMS Electrode") addressing breath analysis of controlled substances. Additional patent applications cover the company's Mass Spectrometer Breath Sampler technology and sample delivery systems for detecting low and semi-volatile substances like delta-9 THC from breath samples.

Target Markets and Applications

Law enforcement agencies represent a key market segment for THC breath testing technology. Traditional roadside impairment testing lacks quantitative measurement tools for recent cannabis use. Breath-based THC detection could provide officers with field testing capabilities similar to those used for alcohol impairment assessment. The technology addresses the gap between legal cannabis consumption and the need to identify potentially impaired drivers.

Workplace safety applications focus on pre-access and post-incident testing scenarios. Industries with safety-sensitive positions require methods to identify recent substance use that may affect job performance or create hazardous conditions. Current drug testing methods often detect historical use rather than recent consumption, potentially missing relevant impairment windows while flagging individuals who used substances days earlier during off-duty hours.

The expansion of cannabis legalization across multiple jurisdictions has created regulatory and safety challenges. Employers and law enforcement agencies seek testing methods that distinguish recent use from past consumption. Breath-based detection approaches aim to fill this role by targeting detection windows measured in hours rather than days or weeks.

Strategic Partnerships

The company maintains a development and commercialization agreement with Omega Laboratories Inc., a forensic drug testing organization with expertise in laboratory analysis and testing protocols. This partnership supports the development pathway for the MBT technology, combining Cannabix's device innovations with established laboratory testing infrastructure and regulatory knowledge.

Distribution agreements extend the company's market reach into international territories. Arrangements with regional distributors facilitate product availability in markets outside North America, particularly for the BreathLogix alcohol screening systems where regulatory approvals and workplace safety standards vary by jurisdiction.

Research and Development

The company's R&D efforts focus on advancing detection sensitivity, reducing device size, improving user ergonomics, and enhancing battery life for field-deployed units. Iterative hardware development addresses practical deployment considerations including environmental durability, maintenance requirements, and operational ease of use in real-world settings.

Laboratory analysis method development continues alongside hardware improvements. The company works to refine sample preservation techniques, optimize detection thresholds, and validate testing protocols against regulatory standards for forensic and workplace testing applications. These efforts aim to build the scientific foundation supporting regulatory approval processes and customer acceptance in law enforcement and workplace safety markets.

Company Background

Cannabix Technologies Inc. was incorporated in 2011 and is headquartered in Burnaby, British Columbia, Canada. The company previously operated as West Point Resources Inc. before changing its name in August 2014 to reflect its strategic focus on breath-based substance detection technologies. The shift from mineral exploration to technology development represents a fundamental business transformation aligning with emerging opportunities in cannabis testing and workplace safety markets.